Literature DB >> 6303375

Lack of interaction between ranitidine and phenytoin.

R W Watts, D J Hetzel, F Bochner, J F Hallpike, C S Hann, D J Shearman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6303375      PMCID： PMC1427794          DOI： 10.1111/j.1365-2125.1983.tb01538.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  8 in total

1.  Cimetidine interaction with warfarin.

Authors:  D Hetzel; D Birkett; J Miners
Journal:  Lancet       Date:  1979-09-22       Impact factor: 79.321

2.  Failure of ranitidine to interact with propranolol.

Authors:  A M Heagerty; C M Castleden; L Patel
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-01

3.  Cimetidine interaction with phenytoin.

Authors:  D J Hetzel; F Bochner; J F Hallpike; D J Shearman; C S Hann
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-09

Review 4.  Drug interactions with cimetidine.

Authors:  A Somogyi; R Gugler
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

5.  Lack of effect of ranitidine on warfarin action.

Authors:  M J Serlin; R G Sibeon; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

6.  Cimetidine: interaction with oral anticoagulants in man.

Authors:  M J Serlin; R G Sibeon; S Mossman; A M Breckenridge; J R Williams; J L Atwood; J M Willoughby
Journal:  Lancet       Date:  1979-08-18       Impact factor: 79.321

7.  Cimetidine-phenytoin interaction: effect on serum phenytoin concentration and antipyrine test.

Authors:  P J Neuvonen; R A Tokola; M Kaste
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

8.  Cimetidine and ranitidine: comparison of effects on hepatic drug metabolism.

Authors:  D A Henry; I A Macdonald; G Kitchingman; G D Bell; M J Langman
Journal:  Br Med J       Date:  1980-09-20
  8 in total
  10 in total

1.  Drug interactions through binding to cytochrome p 450: the experience with h2-receptor blocking agents.

Authors:  U Klotz; I W Reimann
Journal:  Pharm Res       Date:  1984-03       Impact factor: 4.200

Review 2.  Pharmacokinetic drug interactions with phenytoin (Part II).

Authors:  R L Nation; A M Evans; R W Milne
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 4.  Ranitidine versus cimetidine. A comparison of their potential to cause clinically important drug interactions.

Authors:  S R Smith; M J Kendall
Journal:  Clin Pharmacokinet       Date:  1988-07       Impact factor: 6.447

Review 5.  Side effects of ranitidine.

Authors:  T Vial; C Goubier; A Bergeret; F Cabrera; J C Evreux; J Descotes
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

6.  A comparison of the influence of famotidine and cimetidine on phenytoin elimination and hepatic blood flow.

Authors:  N C Sambol; R A Upton; A N Chremos; E T Lin; R L Williams
Journal:  Br J Clin Pharmacol       Date:  1989-01       Impact factor: 4.335

7.  The effect of ranitidine and cimetidine on imipramine disposition.

Authors:  B G Wells; J A Pieper; T H Self; C F Stewart; S L Waldon; L Bobo; C Warner
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 8.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

Review 9.  Interactions and non-interactions with ranitidine.

Authors:  W Kirch; H Hoensch; H D Janisch
Journal:  Clin Pharmacokinet       Date:  1984 Nov-Dec       Impact factor: 6.447

10.  Dose and concentration dependent effect of ranitidine on procainamide disposition and renal clearance in man.

Authors:  A Somogyi; F Bochner
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.